Indiana Biobank launches pilot grant program
Sept. 19, 2013
The Indiana Biobank has launched its first pilot funding application specifically designed to promote research studies using the samples in IB.
Applications to this program are expected to have a maximum requested amount of $10,000. The submission deadline is 5 p.m. Monday, Nov. 11.
The Indiana Biobank was established in 2010 as a statewide resource of biosamples that are linked to electronic medical records. Initial funding to establish infrastructure was provided by a grant from the Lilly Endowment with additional support provided by the Indiana Clinical and Translational Sciences Institute, a partnership among Indiana University, Purdue University and the University of Notre Dame through a Clinical and Translational Sciences Award from the National Center for Advancing Translational Research at the National Institutes of Health.
The Indiana Biobank aims to assist in the consenting of subjects and the collection of blood and saliva samples. The mission of the Indiana Biobank is to create a collection of well characterized biosamples that can serve as a research resource to enhance translational research. To date, samples and data from more than 11,000 individuals have been collected through 25 different hospitals or clinics.
Samples are either blood or saliva that can be used for DNA extraction. Samples are available from both pediatric and adult populations. All samples are linked through the medical record number (MRN) to the Indiana Network for Patient Care (INPC). INPC was established in 1995 as the Regional Health Information Exchange. Typically, data from multiple clinical encounters are available.
All subjects were consented to link their biological samples to the electronic medical record. In addition, subjects were consented to allow for broad, unspecified future research use of their samples. Thus, broad based biomedical hypotheses can be addressed using these samples. Summary information is available for the samples for particular disorders in the application materials. However, it is expected as part of this proposal that researchers may need additional information about the number of individuals who meet criteria for particular disease and/or have been prescribed specific medications, or experience an adverse event. If the project is selected for potential funding, the investigators will work with the Indiana Biobank and the Indiana CTSI Data Core to identify subjects meeting more specific diagnostic criteria.
All costs to obtain DNA from Indiana Biobank as well as to obtain a clinical dataset for the subject will be subsidized. In addition, the investigator can request funds to support the proposed pilot studies.
Projects typically are one year in duration. Funding for up to three projects is planned.
To learn about this grant program, or access the application form, visit www.indianactsi.org/grants and log in using your institutional username and password.
Applications instructions are under “Pilot Funding for Research Use of Indiana Biobank (IB) Samples - 2013.11 (PIB).”
For questions about financial issues related to budgeting and grant submissions, contact Lisa Dinsmore at email@example.com